Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Mucuna sloanei
Tropical liana of West Africa and South America used in traditional medicine for pain, inflammation, and as a snake venom antidote.
Mucuna sloanei is a tropical liana used in West African and South American traditional medicine for snakebite, pain, and inflammation. Its seeds and roots contain L-DOPA, alkaloids, flavonoids, and lectins, which contribute to its dopaminergic, analgesic, and anti-inflammatory properties. Modern research is limited but suggests potential in neuroprotection and antivenom applications.
L-DOPA from Mucuna sloanei crosses the blood-brain barrier and is converted to dopamine, activating D1/D2 receptors, which may explain its nervine and neuroprotective effects. Alkaloids and flavonoids inhibit cyclooxygenase (COX) and lipoxygenase (LOX) pathways, reducing prostaglandin and leukotriene synthesis, thereby providing analgesic and anti-inflammatory actions. Lectins and tannins may bind venom proteins, neutralizing toxicity, though this mechanism is primarily traditional and requires further validation.
Tropical liana of West Africa and South America used in traditional medicine for pain, inflammation, and as a snake venom antidote.
Mucuna sloanei is a tropical liana used in West African and South American traditional medicine for snakebite, pain, and inflammation. Its seeds and roots contain L-DOPA, alkaloids, flavonoids, and lectins, which contribute to its dopaminergic, analgesic, and anti-inflammatory properties. Modern research is limited but suggests potential in neuroprotection and antivenom applications.
L-DOPA from Mucuna sloanei crosses the blood-brain barrier and is converted to dopamine, activating D1/D2 receptors, which may explain its nervine and neuroprotective effects. Alkaloids and flavonoids inhibit cyclooxygenase (COX) and lipoxygenase (LOX) pathways, reducing prostaglandin and leukotriene synthesis, thereby providing analgesic and anti-inflammatory actions. Lectins and tannins may bind venom proteins, neutralizing toxicity, though this mechanism is primarily traditional and requires further validation.